Antithyroglobulin antibody as a marker of successful ablation therapy in differentiated thyroid cancer

The aim of this study was to determine the role of antithyroglobulin antibody (ATA) serum as a marker of successful I-131 ablation therapy in differentiated thyroid cancer (DTC) patients with low serum thyroglobulin (Tg). A retrospective study was conducted on 60 patients (10 males and 50 females)....

Full description

Saved in:
Bibliographic Details
Main Authors: Ayu Dewi, Budi Darmawan, Achmad Kartamihadja, Basuki Hidayat, Johan Masjhur
Format: Article
Language:English
Published: Thieme Medical and Scientific Publishers Pvt. Ltd. 2017-01-01
Series:World Journal of Nuclear Medicine
Subjects:
Online Access:http://www.thieme-connect.de/DOI/DOI?10.4103/1450-1147.174714
Tags: Add Tag
No Tags, Be the first to tag this record!